Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Karolina Jonsson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Infectious Diseases|April 6, 2004
Sexually transmitted herpes simplex virusesMaria Karolina Jonsson, Britta Wahren
Annals of the Rheumatic Diseases|January 12, 2018
Response to: 'Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis' by Chevreau <i>et al</i>Maria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal, et al.
Annals of the Rheumatic Diseases|April 21, 2016
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteriaLena Bugge Nordberg, Siri Lillegraven, Elisabeth Lie, et al.
Arthritis Research & Therapy|July 14, 2018
The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapyMaria Karolina Jonsson, Aase Haj Hensvold, Monika Hansson, et al.
Annals of the Rheumatic Diseases|August 18, 2017
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritisMaria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal, et al.
Trials|February 18, 2026
Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trialSiri Opsahl Hetlevik, Vibke Lilleby, Maiju Pesonen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Infectious Diseases|April 6, 2004
Sexually transmitted herpes simplex virusesMaria Karolina Jonsson, Britta Wahren
Annals of the Rheumatic Diseases|January 12, 2018
Response to: 'Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis' by Chevreau <i>et al</i>Maria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal, et al.
Annals of the Rheumatic Diseases|April 21, 2016
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteriaLena Bugge Nordberg, Siri Lillegraven, Elisabeth Lie, et al.
Arthritis Research & Therapy|July 14, 2018
The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapyMaria Karolina Jonsson, Aase Haj Hensvold, Monika Hansson, et al.
Annals of the Rheumatic Diseases|August 18, 2017
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritisMaria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal, et al.
Trials|February 18, 2026
Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trialSiri Opsahl Hetlevik, Vibke Lilleby, Maiju Pesonen, et al.
Pageof 1